Eton Pharmaceuticals (ETON) EBIT Margin (2019 - 2025)
Eton Pharmaceuticals' (ETON) quarterly EBIT Margin came in at 11.05% in Q4 2025, down 978.0% year-on-year from 1.26% in Q4 2024, and up 282.04% quarter-over-quarter from 6.07% in Q3 2025.
Eton Pharmaceuticals (ETON) EBIT Margin (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals has disclosed EBIT Margin across 7 years of filings, most recently posting 11.05% for Q4 2025.
- EBIT Margin for Q4 2025 came in at 11.05%, down 978.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1.48% (up 57.0% YoY), and the FY2025 annual result was 1.2%, up 85.0% from the prior year.
- EBIT Margin came in at 11.05% for Q4 2025 at Eton Pharmaceuticals, up from 6.07% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 87.41% in Q4 2022 to a low of 754.45% in Q3 2021.
- The 5-year median for EBIT Margin is 7.8% (2023), against an average of 55.12%.
- Peak annual rise in EBIT Margin reached 2261419 bps in 2021, while the deepest fall reached 24731177 bps in 2021.
- Eton Pharmaceuticals' EBIT Margin stood at 21.57% in 2021, then soared by 305 bps to 87.41% in 2022, then tumbled by 108 bps to 6.69% in 2023, then soared by 411 bps to 20.83% in 2024, then slumped by 47 bps to 11.05% in 2025.
- The last three EBIT Margin figures came in at 11.05% (Q4 2025), 6.07% (Q3 2025), and 7.79% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Eton Pharmaceuticals | 820.42 Mn | 794.48 Mn | 13.10 Mn | 11.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.05% |
| Sep 30, 2025 | -6.07% |
| Jun 30, 2025 | -7.79% |
| Mar 31, 2025 | -26.32% |
| Dec 31, 2024 | 20.83% |
| Sep 30, 2024 | 4.93% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -10.04% |
| Dec 31, 2023 | -6.69% |
| Sep 30, 2023 | -7.80% |
| Jun 30, 2023 | 32.37% |
| Mar 31, 2023 | -47.78% |
| Dec 31, 2022 | 87.41% |
| Sep 30, 2022 | -89.93% |
| Jun 30, 2022 | -26.80% |
| Mar 31, 2022 | -233.78% |
| Dec 31, 2021 | 21.57% |
| Sep 30, 2021 | -754.45% |
| Jun 30, 2021 | -75.81% |
| Mar 31, 2021 | 45.08% |